fructosamine has been researched along with glyburide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grunberger, G | 1 |
| Buckley, GC; Jenkins, AL; Jenkins, DJ; Josse, RG; Vuksan, V; Wolever, TM; Wong, GS | 1 |
| Bailey, CJ; Billingham, MS; Hall, RA; Milles, JJ | 1 |
| Barnett, AH; Florkowski, CM; Jennings, PE; Jones, AF; Le Guen, C; Lunec, J; O'Donnell, MJ; Richardson, MR | 1 |
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Kruseman, AC; Menheere, PP; Müller, PG; Nijst, L; Sels, JP; Wolffenbuttel, BH | 1 |
| Chan, JC; Cockram, CS; Critchley, JA; Tomlinson, B; Walden, RJ | 1 |
| Belkhadir, J; el Ghomari, H; Klöcker, N; Mikou, A; Nasciri, M; Sabri, M | 1 |
| Menheere, PP; Nieuwenhuijzen Kruseman, AC; Rondas-Colbers, GJ; Sels, JP; Wolffenbuttel, BH | 1 |
| Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T | 1 |
| Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
| Allavoine, T; Howlett, H; Lehert, P; Marre, M | 1 |
| Mafauzy, M | 1 |
| Bruce, S; Dandona, P; Donovan, DS; Garber, AJ; Park, JS | 1 |
| Harman-Boehm, I; Hershkovitz, T; Mouritzen, U; Raz, I; Vaz, J; Wainstein, J | 1 |
| Chakraborti, AS; Roy, M; Sen, S | 1 |
| Erejuwa, OO; Gurtu, S; Salleh, MS; Sirajudeen, KN; Sulaiman, SA; Wahab, MS | 1 |
11 trial(s) available for fructosamine and glyburide
| Article | Year |
|---|---|
Maintenance of sulfonylurea responsiveness in NIDDM. Randomized double-blind study of intermittent glyburide therapy.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Administration Schedule; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Male; Middle Aged; Prospective Studies | 1992 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Piperidines; Tolbutamide | 1993 |
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cardiac Output; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Heart Rate; Hemodynamics; Hexosamines; Humans; Male; Metformin; Middle Aged; Posture; Triglycerides; Vascular Resistance | 1993 |
Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemia; Islam; Male; Middle Aged | 1993 |
Comparison of different insulin regimens in elderly patients with NIDDM.
Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Costs and Cost Analysis; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lipids; Lipoprotein(a); Male; Netherlands; Triglycerides | 1996 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fructosamine; Gastrointestinal Diseases; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Tablets; Treatment Outcome | 2002 |
Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.
Topics: Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Fasting; Feeding Behavior; Female; Fructosamine; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Islam; Malaysia; Male; Middle Aged; Piperidines; Risk Factors; Safety; Time Factors | 2002 |
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Postprandial Period | 2003 |
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
Topics: Adult; Aged; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2003 |
6 other study(ies) available for fructosamine and glyburide
| Article | Year |
|---|---|
Beneficial effect of a low glycaemic index diet in type 2 diabetes.
Topics: Aged; Biomarkers; Blood Glucose; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Energy Intake; Female; Fructosamine; Glyburide; Hexosamines; Humans; Insulin; Male; Triglycerides; Urea | 1992 |
Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Topics: Alcohol Drinking; Apolipoproteins; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Lipoproteins; Male; Middle Aged; Reference Values; Smoking; Triglycerides | 1989 |
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Immunoglobulin G; Lipid Peroxides; Male; Platelet Aggregation; Sulfonylurea Compounds; Thromboxane B2 | 1988 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides | 1996 |
Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats.
Topics: Animals; Blood Glucose; Catalase; Cholesterol; Diabetes Mellitus, Experimental; Free Radicals; Fructosamine; Glucose Intolerance; Glyburide; Glycated Hemoglobin; Glycyrrhizic Acid; Hemoglobins; Hyperglycemia; Hyperlipidemias; Insulin; Islets of Langerhans; Kidney; Male; Malondialdehyde; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Superoxide Dismutase | 2011 |
Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats.
Topics: Animals; Bilirubin; Blood Glucose; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Eating; Fructosamine; Glyburide; Honey; Hypoglycemic Agents; Insulin; Male; Metformin; Rats; Rats, Sprague-Dawley | 2011 |